MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  You, Jiacong ^a   Li, Yang ^a   Fang, Nianzhen ^a   Liu, Bin ^a   Zu, Lingling ^a   Chang, Rui ^a   Li, Xuebing ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MICRORNA 132; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; 3' UNTRANSLATED REGION; HOMEODOMAIN PROTEIN; MICRORNA; MIRN132 MICRORNA, HUMAN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING KINETICS; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; DOWN REGULATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; NON SMALL CELL LUNG CANCER; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

3' UNTRANSLATED REGIONS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS;

EID: 84897990289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091827     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Chaffer CL, Weinberg RA (2011) A perspective on cancer cell metastasis. Science 331: 1559-1564.
3. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
4. Bartel DP, Chen CZ (2004) Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5: 396-400. (Pubitemid 38529411)
5. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86. (Pubitemid 38055775)
6. Kim VN (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
7. Wang QY, Tang J, Zhou CX, Zhao Q (2012) [The down-regulation of miR-129 in breast cancer and its effect on breast cancer migration and motility]. Sheng Li Xue Bao 64: 403-411.
8. Lin Y, Wu J, Chen H, Mao Y, Liu Y, et al. (2012) Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBS Lett 586: 442-447.
9. Wang J, Gu Z, Ni P, Qiao Y, Chen C, et al. (2011) NF-kappaB P50/P65 heterodimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop. Nucleic Acids Res 39: 6440-6455.
10. Suzuki H, Tokino T, Shinomura Y, Imai K, Toyota M (2008) DNA methylation and cancer pathways in gastrointestinal tumors. Pharmacogenomics 9: 1917-1928.
11. Yang D, Li T, Wang Y, Tang Y, Cui H, et al. (2012) miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci 125: 1673-1682.
12. Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, et al. (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat Med 16: 909-914.
13. Zhang S, Hao J, Xie F, Hu X, Liu C, et al. (2011) Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 32: 1183-1189.
14. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428. (Pubitemid 46809165)
15. Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, et al. (2011) ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett 300: 66-78.
16. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates Ecadherin and induces invasion. Mol Cell 7: 1267-1278. (Pubitemid 32607360)
17. Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, et al. (1999) New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J 18: 5073-5084. (Pubitemid 29443809)
18. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, et al. (2005) SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 33: 6566-6578. (Pubitemid 41806421)
19. Bindels S, Mestdagt M, Vandewalle C, Jacobs N, Volders L, et al. (2006) Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25: 4975-4985.
20. Zhou Q, Wang Y, Che G, Zhu W, Chen X, et al. (2003) [Establishment and their biological characteristics of clonal cell subpopulations (NL9980 and L9981) from a human lung large cell carcinoma cell line (WCQH-9801)]. Zhongguo Fei Ai Za Zhi 6: 464-468.
21. Li CY, Tan L, Zhang GJ, Li P, Tong C, et al. (2004) Transcriptional regulation of urokinase receptor in high- (95D) and low-metastatic (95C) human lung cancer cells. Acta Biochim Biophys Sin (Shanghai) 36: 405-411. (Pubitemid 39091571)
22. Liu H, Li Y, Liu B, Wu H, Wang J, et al. (2012) Cloning and functional analysis of FLJ20420: a novel transcription factor for the BAG-1 promoter. PLoS One 7: e34832.
23. Wang R, Wang ZX, Yang JS, Pan X, De W, et al. (2011) MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30: 2644-2658.
24. Liu S, Li L, Zhang Y, Zhao Y, You X, et al. (2012) The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells. J Biol Chem 287: 30228-30239.
25. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
26. Kang HW, Crawford M, Fabbri M, Nuovo G, Garofalo M, et al. (2013) A mathematical model for microRNA in lung cancer. PLoS One 8: e53663.
27. Sanfiorenzo C, Ilie MI, Belaid A, Barlesi F, Mouroux J, et al. (2013) Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS One 8: e54596.
28. Miao LJ, Huang SF, Sun ZT, Gao ZY, Zhang RX, et al. (2013) MiR-449c targets c-Myc and inhibits NSCLC cell progression. FEBS Lett 587: 1359-1365.
29. Liu B, Wu X, Wang C, Liu Y, Zhou Q, et al. (2012) MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 1822: 1692-1704.
30. Remenyi J, Hunter CJ, Cole C, Ando H, Impey S, et al. (2010) Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 428: 281-291.
31. Usova EV, Kopantseva MR, Kostina MB, Van'kovich AN, Egorov VI, et al. (2013) Expression of the ZEB2 gene in pancreatic stromal cells in pancreatic ductal adenocarcinoma, pancreatitis, and normal state. Dokl Biol Sci 448: 61-64.
32. Lee JY, Park MK, Park JH, Lee HJ, Shin DH, et al. (2013) Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Oncogene. In press.
33. Cong N, Du P, Zhang A, Shen F, Su J, et al. (2013) Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol Rep 29: 1579-1587.
34. Dai YH, Tang YP, Zhu HY, Lv L, Chu Y, et al. (2012) ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells. Dig Dis Sci 57: 1253-1260.
35. Henrion M, Frampton M, Scelo G, Purdue M, Ye Y, et al. (2013) Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer. Hum Mol Genet 22: 825-831.
36. Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, et al. (2013) Epithelial- mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. Oral Oncol 49: 34-41.
37. Qi S, Song Y, Peng Y, Wang H, Long H, et al. (2012) ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PLoS One 7: e38842.
38. Cai MY, Luo RZ, Chen JW, Pei XQ, Lu JB, et al. (2012) Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma. PLoS One 7: e32838.
39. Wu Q, Guo R, Lin M, Zhou B, Wang Y (2011) MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. Gynecol Oncol 122: 149-154.
40. Koopmansch B, Berx G, Foidart JM, Gilles C, Winkler R (2013) Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression. Biochem Biophys Res Commun 431: 652-657.
41. Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, et al. (2012) MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol 19 Suppl 3: S656-664.
42. Nam EH, Lee Y, Park YK, Lee JW, Kim S (2012) ZEB2 upregulates integrin alpha5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. Carcinogenesis 33: 563-571.
43. Brabletz T (2012) EMT and MET in metastasis: where are the cancer stem cells? Cancer Cell 22: 699-701.